Table 4. Chronic intramedullary lesion, cavitation, mCSA and SCA distribution among patients with positive and negative outcome and initial neurological grades IV and V.
| Chronic IL | Chronic IC | Chronic IL extending beyond SCI epicentre | Post-traumatic syringomyelia | Length of IL (median, range) | Length of IC (median, range) | Mild mCSA | Moderate mCSA | Severe mCSA | SCA | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IL | IC | IL | IC | IL | IC | ||||||||
| Positive outcome | 18/21 | 16/21 | 9/21 | 6/21 | 1.66/4.66 | 0.36/2 | 13/21 | 12/21 | 4/21 | 3/21 | 1/21 | 1/21 | 16/21 |
| Negative outcome | 16/16 | 16/16 | 13/16 | 12/16 | 5.32/10.35 | 4.22/9.39 | 2/16 | 6/16 | 4/16 | 8/16 | 10/16 | 2/16 | 16/16 |
| Grade IV | 13/16 | 11/16 | 5/16 | 4/16 | 1.60/4.92 | 0.29/4.38 | 11/16 | 10/16 | 1/16 | 0/16 | 1/16 | 1/16 | 11/16 |
| Grade V | 10/10 | 10/10 | 8/10 | 6/10 | 4.01/8.09 | 1.70/3.77 | 4/10 | 5/10 | 3/10 | 4/10 | 3/10 | 1/10 | 10/17 |
IL–intramedullary lesions, IC–intramedullary cavitations, mCSA–maximal cross-sectional area, SCA–spinal cord atrophy.